Vertex Pharmaceuticals (VRTX) Times Interest Earned (2009 - 2025)

Vertex Pharmaceuticals' Times Interest Earned history runs 18 years deep, the most recent figure standing at $2.71 for Q1 2026.

• In Q1 2026, Times Interest Earned rose 53.59% year-over-year to $2.71; the TTM figure through Mar 2026 stood at $11.14 (up 636.27% YoY), while the FY2025 annual figure was $9.56, up 1501.17% from the prior year.
• Times Interest Earned for Q1 2026 stood at $2.71, down from $22.71 in the prior quarter.
• The five-year high for Times Interest Earned was $89.86 in Q4 2023, with the low at -$11.36 in Q2 2024.
• The 5-year median for Times Interest Earned is $4.1 (2023), against an average of $15.73.
• The sharpest annual moves came in 2022 and 2024: Times Interest Earned soared 1798.73% in 2022, then sank 377.22% in 2024.
• Vertex Pharmaceuticals' Times Interest Earned stood at $75.44 in 2022, then climbed by 19.12% to $89.86 in 2023, then slumped by 53.4% to $41.88 in 2024, then slumped by 45.77% to $22.71 in 2025, then slumped by 88.08% to $2.71 in 2026.
• Business Quant data shows VRTX's Times Interest Earned at $2.71 in Q1 2026, $22.71 in Q4 2025, and $2.81 in Q3 2025.